Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5286 USD | -0.94% | -6.85% | -58.05% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 29.02M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-
| Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
1 day | -0.94% | ||
1 week | -6.85% | ||
Current month | -57.37% | ||
1 month | -57.71% | ||
3 months | -56.49% | ||
6 months | -83.32% | ||
Current year | -58.05% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.5286 | -0.94% | 778,922 |
24-03-27 | 0.5336 | +0.47% | 2,293,421 |
24-03-26 | 0.5311 | -6.17% | 863,144 |
24-03-25 | 0.566 | -1.67% | 1,299,093 |
24-03-22 | 0.5756 | +1.43% | 780,946 |
Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.05% | 29.02M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |